Triple

T3520321
Position Surface form Disambiguated ID Type / Status
Subject Emmanuelle Charpentier E74405 entity
Predicate coInventorOf P1858 FINISHED
Object CRISPR-Cas9 gene-editing method E366097 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CRISPR-Cas9 gene-editing method | Statement: [Emmanuelle Charpentier, coInventorOf, CRISPR-Cas9 gene-editing method]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: CRISPR-Cas9 gene-editing method
Context triple: [Emmanuelle Charpentier, coInventorOf, CRISPR-Cas9 gene-editing method]
  • A. CRISPR-Cas9 gene-editing technology chosen
    CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
  • B. Yamanaka factors
    Yamanaka factors are a set of transcription factors that can reprogram adult somatic cells into induced pluripotent stem cells, revolutionizing regenerative medicine and stem cell research.
  • C. CLARITY tissue-clearing method
    CLARITY is a neuroscience technique that renders biological tissues transparent while preserving their molecular structure, enabling high-resolution, three-dimensional imaging of intact organs such as the brain.
  • D. Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc
    Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc are a set of transcription factors whose forced expression can reprogram differentiated somatic cells into induced pluripotent stem cells.
  • E. Szostak Design
    Szostak Design is an architectural firm known for designing prominent cultural and performing arts venues, including the Durham Performing Arts Center in North Carolina.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ad85d0c5488190a3d8e02ebd01a1aa completed March 8, 2026, 2:21 p.m.
NER Named-entity recognition batch_69adbc4af70c8190a7471f28e1efd7fd completed March 8, 2026, 6:13 p.m.
NED1 Entity disambiguation (via context triple) batch_69b38bc74a208190b3fe59e7b56a3d0d completed March 13, 2026, 4 a.m.
Created at: March 8, 2026, 3:19 p.m.